It has been previously described that A2BAR activation decreased the expression of epithelial markers (E-cadherin) and enhanced mesenchymal markers (Vimentin, N-cadherin) during pulmonary fibrosis (46). The gene discussed is CDH1; the disease is pulmonary fibrosis.